Verrica Pharmaceuticals I... (VRCA)
NASDAQ: VRCA
· Real-Time Price · USD
5.93
-0.22 (-3.58%)
At close: Aug 15, 2025, 3:59 PM
5.96
0.51%
After-hours: Aug 15, 2025, 04:10 PM EDT
Verrica Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 12.7M | 3.44M | 344K | -1.78M | 5.18M | 3.83M | 1.99M | 2.92M | 182K | 37K | 68K | 8.32M | 214K | 431K | -12M | n/a | n/a | 12M |
Cost of Revenue | 340K | 423K | 625K | 435K | 542K | 1.14M | 380.5K | 145K | 136K | 68K | 62K | 2.95M | 163K | 158K | 200K | 111K | 94K | n/a |
Gross Profit | 12.36M | 3.02M | -281K | -2.22M | 4.63M | 2.69M | 1.61M | 2.77M | 46K | -31K | 6K | 5.37M | 51K | 273K | -12.2M | -111K | -94K | 12M |
Operating Income | 1.51M | -8.13M | -11.41M | -20.7M | -15.21M | -18.6M | -20.6M | -23.92M | -11.62M | -7.09M | -6.21M | 1.45M | -9.12M | -7.41M | -8.47M | -11.77M | -10.73M | 60K |
Interest Income | 228K | 337K | 205K | 221K | 393K | 598K | 792K | 822K | 626K | 500K | 287K | 148K | 20K | 22K | 27K | 31K | 33K | 32K |
Pretax Income | 204K | -9.74M | -16.2M | -22.86M | -17.19M | -20.33M | -24.61M | -24.8M | -10.99M | -6.59M | -5.93M | 83K | -10.17M | -8.47M | -9.54M | -12.83M | -11.78M | -936K |
Net Income | 204K | -9.74M | -16.2M | -22.86M | -17.19M | -20.33M | -24.61M | -24.8M | -10.99M | -6.59M | -5.65M | 83K | -11.21M | -9.53M | -9.54M | -12.83M | -11.78M | -936K |
Selling & General & Admin | 8.85M | 8.85M | 9.88M | 16.08M | 16.52M | 16.34M | 17M | 20.05M | 5.94M | 4.32M | 3.19M | 3.92M | 5.17M | 5.12M | 5.11M | 8.01M | 7.28M | 6.58M |
Research & Development | 1.85M | 2.28M | 1.17M | 2.4M | 3.32M | 4.95M | 5.32M | 6.51M | 5.72M | 2.74M | 3.03M | 2.95M | 4.16M | 2.72M | 3.36M | 3.76M | 3.45M | 5.36M |
Other Expenses | 154K | 14K | 84K | n/a | n/a | n/a | -108.5K | 125K | n/a | n/a | -6K | 5K | -1K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 10.85M | 11.15M | 11.13M | 18.49M | 19.84M | 21.29M | 22.21M | 26.69M | 11.66M | 7.06M | 6.22M | 6.87M | 9.34M | 7.84M | 8.47M | 11.77M | 10.73M | 11.94M |
Interest Expense | 2.13M | 2.2M | 2.35M | 2.38M | 2.37M | 2.32M | 2.31M | 1.66M | n/a | n/a | n/a | 81K | 1.07M | 1.08M | 1.1M | 1.09M | 1.08M | 1.03M |
Selling & Marketing Expenses | n/a | 300K | 3.7M | 1.1M | 1.1M | 1.5M | 3.5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 11.19M | 11.57M | 11.75M | 18.92M | 20.38M | 22.43M | 25.12M | 26.83M | 11.8M | 7.13M | 6.28M | 6.87M | 9.34M | 7.84M | 8.47M | 11.77M | 10.73M | 11.94M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -281K | n/a | 1.05M | 1.06M | n/a | 31K | 33K | n/a |
Shares Outstanding (Basic) | 9.49M | 9.48M | 6.73M | 4.68M | 4.65M | 4.65M | 4.63M | 4.61M | 4.59M | 4.3M | 4.11M | 4.03M | 2.75M | 2.75M | 2.75M | 2.75M | 2.75M | 2.56M |
Shares Outstanding (Diluted) | 9.49M | 9.48M | 6.73M | 4.68M | 4.65M | 4.65M | 4.63M | 4.61M | 4.59M | 4.3M | 4.11M | 4.47M | 2.75M | 2.75M | 2.75M | 2.75M | 2.75M | 2.56M |
EPS (Basic) | 0.02 | -1.03 | -2.41 | -4.88 | -3.7 | -4.37 | -5.31 | -5.38 | -2.39 | -1.53 | -1.44 | 0.02 | -3.69 | -3.08 | -3.47 | -4.66 | -4.28 | -0.37 |
EPS (Diluted) | 0.02 | -1.03 | -2.41 | -4.88 | -3.7 | -4.37 | -5.31 | -5.38 | -2.39 | -1.53 | -1.44 | 0.02 | -3.69 | -3.08 | -3.47 | -4.66 | -4.28 | -0.37 |
EBITDA | 2.53M | -8.13M | -13.6M | -20.14M | -14.48M | -17.67M | -22.09M | -22.93M | -10.78M | -6.39M | -5.73M | 360K | -8.94M | -7.23M | -8.24M | -11.63M | -10.6M | 159K |
EBIT | 2.33M | -7.54M | -13.85M | -20.48M | -14.82M | -18.01M | -22.31M | -23.14M | -10.99M | -6.59M | -5.93M | 1.45M | -9.1M | -7.39M | -8.44M | -11.74M | -10.7M | 92K |
Depreciation & Amortization | 199K | 208K | 253K | 342K | 334K | 340K | 217K | 210K | 207K | 202K | 201K | 127K | 163K | 158K | 200K | 111K | 94K | 67K |